Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pilot inspection project shows 'Kumbaya approach' works well for US, Europe

This article was originally published in Scrip

Executive Summary

In an era of divided government in the US, with Republicans and Democrats at each other's throats, the US FDA has opted for a more "Kumbaya" approach with its international colleagues, reaching out to European and Australian regulators in an effort to establish a sense of mutual trust and common purpose for protecting the global drug supply.